- Jieun Lee, Jeong-Ju Yoo. The current state of graphical abstracts and how to create good graphical abstracts. Sci Ed 2023;10:19

- Younghee Choe. Antibiotic Resistance and Helicobacter pylori Eradication Therapy. Korean J Helicobacter Up Gastrointest Res 2023;23:218

- E. A. Ortenberg, M. V. Lyapina, E. F. Dorodnyeva. Competitive proton pump inhibitors - status and Prospects of use. jour 2023:86

- Hye Kyung Jeon, Gwang Ha Kim, Yong-Il Cheon, Sung-Chan Shin, Byung Joo Lee. Efficacy of Tegoprazan in Patients with Laryngopharyngeal Reflux Disease: A Preliminary Feasibility Study. JCM 2023;12:6116

- Jin Hee Noh, Kee Don Choi. Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2023;23:228

- Seong Hyun Cho, Moon Sik Park, Seon-Young Park, Dong Hyun Kim, Hye-Su You, Hyun-Soo Kim. Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area. Front. Med. 2023;10

- Byeong Yun Ahn, Soo-Jeong Cho. Potassium-competitive Acid Blockers: A New Therapeutic Strategy for Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2023;23:174

- Caio Constantini Rosa, Jessé Rodrigues de Moraes. Tratamento Das Infecções Por Helicobacter Pylori: Revisão De Ensaios Clínicos. jmrr 2022;1:e021

- Yoon Jin Choi. Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers. Korean J Gastroenterol 2022;80:247

- Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita. Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments. Gut and Liver 2023;17:684

- Yuichiro Noiri, Ryoko Nagata. Current status of gastric and oral infection/diseases caused by Helicobacter pylori. Oral Science International 2023;20:182

- Sung Eun Kim. Approach to Patients with Consecutive Helicobacter pylori Eradication Failure. Korean J Helicobacter Up Gastrointest Res 2023;23:15

- Joon Sung Kim, Weonjin Ko, Jun‐Won Chung, Tae Ho Kim. Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study. Helicobacter 2023;28

- Abdullah Shah, Omer Usman, Tafseer Zahra, Sandipkumar S Chaudhari, Gopi Sairam Reddy Mulaka, Rumaisa Masood, Saima Batool, Faraz Saleem. Efficacy and Safety of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors as Helicobacter pylori Eradication Therapy: A Meta-Analysis of Randomized Clinical Trials. 2023

- György Miklós Buzás, Péter Birinyi. Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review. Antibiotics 2023;12:946

- Yong Hwan Kwon, Seong Woo Jeon, Su Youn Nam, Dong Wook Lee, Ji Hey Park, Hui Jin Bae. Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication. Korean J Intern Med 2023;38:493

- Jin Lee. Role of Tegoprazan in Helicobacter pylori Eradication Therapy. Gut and Liver 2022;16:493

- Zhuodu Wei, Hyeon-Cheol Jeong, Min-Gul Kim, Kwang-Hee Shin. Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model. Pharmaceuticals 2023;16:360

- Jong Kyu Park. Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers. Korean J Helicobacter Up Gastrointest Res 2023;23:180

- Yoon Suk Jung, Sunyong Kim, Hyun-Young Kim, Seung Jae Noh, Jung Ho Park, Chong Il Sohn, Chan Hyuk Park. Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study. Gut and Liver 2023;17:711

- Hyun Ho Choi. Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?. Gut and Liver 2023;17:668

- Chan Hyuk Park, Myung Jin Song, Byung Wook Jung, Jung Ho Park, Yoon Suk Jung. Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication. JPM 2022;12:1918
